| Issue Date | Title | Author(s) |
| 2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
| 2016-06 | Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis. | Carter, DR; Sutton, SK; Pajic, M; Murray, J; Sekyere, EO; Fletcher, J; Beckers, A; De Preter, K; Speleman, F; George, RE; Haber, M; Norris, MD; Cheung, BB; Marshall, GM |
| 2019 | CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target. | Feng, X; Bai, X; Ni, J; Wasinger, VC; Beretov, J; Zhu, Y; Graham, P; Li, Y |
| 2016-09-13 | A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts. | El-Hoss, J; Jing, D; Evans, K; Toscan, C; Xie, J; Lee, H; Taylor, RA; Lawrence, MG; Risbridger, GP; MacKenzie, KL; Sutton, R; Lock, RB |
| 2017-05-01 | The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. | Wong, M; Tee, AEL; Milazzo, G; Bell, JL; Poulos, RC; Atmadibrata, B; Sun, Y; Jing, D; Ho, N; Ling, D; Liu, PY; Zhang, XD; Hüttelmaier, S; Wong, JWH; Wang, J; Polly, P; Perini, G; Scarlett, CJ; Liu, T |
| 2022-10-12 | Extracellular vesicles from biological fluids as potential markers in castration resistant prostate cancer. | Choi, WWY; Sánchez, C; Li, JJ; Dinarvand, M; Adomat, H; Ghaffari, M; Khoja, L; Vafaee, F; Joshua, AM; Chi, KN; Guns, EST; Hosseini-Beheshti, E |
| 2022-05-03 | Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. | Ho, W-HJ; Law, AMK; Masle-Farquhar, E; Castillo, LE; Mawson, A; O'Bryan, MK; Goodnow, CC; Gallego-Ortega, D; Oakes, SR; Ormandy, CJ |
| 2016-01-07 | ELF5 isoform expression is tissue-specific and significantly altered in cancer. | Piggin, CL; Roden, DL; Gallego-Ortega, D; Lee, HJ; Oakes, SR; Ormandy, CJ |
| 2022-01 | PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. | Li, J; Hlavka-Zhang, J; Shrimp, JH; Piper, C; Dupéré-Richér, D; Roth, JS; Jing, D; Casellas Román, HL; Troche, C; Swaroop, A; Kulis, M; Oyer, JA; Will, CM; Shen, M; Riva, A; Bennett, RL; Ferrando, AA; Hall, MD; Lock, RB; Licht, JD |
| 2017-07-15 | Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL. | Jones, L; Richmond, J; Evans, K; Carol, H; Jing, D; Kurmasheva, RT; Billups, CA; Houghton, PJ; Smith, MA; Lock, RB |
